Leo Burnett Hires Renee Salaberry as Worldwide Strategy Director

Today, Leo Burnett Worldwide announced the appointment of Renee Salaberry to Executive Vice President, Worldwide Strategy Director of Consumer Health. Salaberry will oversee strategy development for the agency’s new global Pfizer Consumer Health business.

In February, Pfizer selected Leo Burnett Worldwide as the creative agency responsible for transitioning the world's #1 heartburn treatment, Nexium from a prescription drug to over-the-counter brand. Salaberry’s vast knowledge and experience in the B2B and B2C healthcare categories will be a key driver in Nexium’s quest to become a globally recognized over-the-counter brand.

“Renee’s wealth of experience and passion for brands that help improve people’s lives make her the perfect person to help drive our strategic partnership with Pfizer,” said Mick McCabe, Chief Strategy Officer of Leo Burnett USA.

With nearly 20 years of strategic consumer and healthcare experience, Salaberry joins Leo Burnett from sister agency Publicis Healthcare Communications Group (PHCG), where she served as Chief Strategy Officer; influencing strategic planning across the PHCG network, including Saatchi & Saatchi Health, Publicis Life Brands, Digitas Health and Razorfish Healthware. Salaberry has led the development of B2B and B2C Global and regional strategies for a variety of blue-chip clients including GE Healthcare, Nestle, Novartis, Abbott, Merck/ Schering Plough and Bausch & Lomb to name just a few.

“Leo Burnett’s move into consumer health recognizes the growing participation of people in their own health and well-being, said Salaberry. “Burnett’s HumanKind philosophy ensures that a brand puts its people at the heart of its strategy. This will be a powerful mindset to driving success for Pfizer’s consumer health portfolio.”

Salaberry will be relocating from Paris to Chicago to take on this important role.